Screener
CytomX Therapeutics CTMX Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $816.39M.
The source filing: CytomX Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-337950
FAQ
- What is CytomX Therapeutics's market capitalization?
- CytomX Therapeutics (CTMX) reported market capitalization of $816.39M in Q2 2026.
- How has CytomX Therapeutics's market capitalization changed year-over-year?
- CytomX Therapeutics's market capitalization increased by 142.1% year-over-year, from $337.14M to $816.39M.
- What is the long-term trend for CytomX Therapeutics's market capitalization?
- Over 5 years (2020 to 2025), CytomX Therapeutics's market capitalization has grown at a 11.1% compound annual growth rate (CAGR), from $427.38M to $721.79M.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about CytomX Therapeutics's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude